Stifel Financial’s Checkpoint Therapeutics CKPT Stock Holding History

Stifel Financial’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,149	Closed	-$41K	–	3487
2025 Q1	$41K	Hold	10,149	–	–	﹤0.01%	3364
2024 Q4	$32.5K	Buy	+10,149	New	+$34.4K	﹤0.01%	3333
2019 Q3	–	Sell	-1,059	Closed	-$33K	–	2871
2019 Q2	$33K	Sell	1,059 -78	-7%	-$3.06K	﹤0.01%	2872
2019 Q1	$33K	Buy	1,137 +11	+1%	+$351	﹤0.01%	2759
2018 Q4	$22K	Sell	1,126 -640	-36%	-$15.2K	﹤0.01%	2638
2018 Q3	$64K	Buy	+1,766	New	+$61.7K	﹤0.01%	2701

Stifel Financial's CKPT Position: Q2 2025 in Review

Stifel Financial sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 10,149 shares — an estimated $41K sold.

Stifel Financial first reported a position in CKPT in Q3 2018 and held it in 6 quarters. The position peaked at $64K in Q3 2018. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Stifel Financial reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Stifel Financial sold 10,149 Checkpoint Therapeutics shares in Q2 2025, an estimated $41K.
Stifel Financial first reported a position in Checkpoint Therapeutics in Q3 2018 and held it in 6 quarters.
Stifel Financial's Checkpoint Therapeutics position peaked at $64K in Q3 2018.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Stifel Financial's 13F filing for Q2 2025, filed 14 Aug 2025.